This content is restricted.
Brief
On August 2023, the Medicines and Healthcare products Regulatory Agency (MHRA) issued an update regarding MHRA outlines intent to speed up patient access to innovative medical devices. The agency is investing in a new Early Access service to provide conditional access to promising technologies ahead of full regulatory approval, particularly for innovative diagnostic devices supporting the NHS's most urgent needs.
Highlights content goes here...
This content is restricted.

RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested